AssayIndex

QYB-2312-K5632

Retatrutide · 10 mg declared · ChinaPeptides Co., Ltd. (QYAOBIO) · manufactured 05 Dec 2023

CHARACTERISEDSHARED BULK
Lot code
QYB-2312-K5632
Supplier
QYB — ChinaPeptides Co., Ltd. (QYAOBIO)
Compound
Retatrutide
Compound class
Incretin analogues and co-agonists
Declared label claim
10mg
Manufacture date
05 Dec 2023
Index quarter
2024-Q2
Independent assays
8
Laboratories involved
VendorInvestigate, Medutest, Janoshik, Nordanalyt
Provenance mix
Buyer-sourced ×4 · Supplier-supplied ×4
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 8
Median purity 98.29% n=8
Spread (max − min) 1.45pp n=8
Standard deviation 0.581pp n=8
95.196.096.897.798.699.4100.3This lot (QYB-2312-K5632)This lot (QYB-2312-K5632): Q1 97.84, median 98.29, Q3 98.76, n=8n=8All RetatrutideAll Retatrutide: Q1 97.75, median 98.41, Q3 98.87, n=496outlier 95.45outlier 95.54outlier 95.67outlier 95.97n=496 Purity (% area)
Figure 1. This lot's independent purity results against the whole Retatrutide record set in the index. The vertical line is the index acceptance specification for the incretin analogues and co-agonists class, 96.5 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 8

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004313QYB-2312-K5632VendorInvestigate2024-Q297.984.89Buyer-sourced3MARGINAL
AX-2024-004314QYB-2312-K5632Medutest2024-Q298.865.56Supplier-supplied4MARGINAL
AX-2024-004315QYB-2312-K5632VendorInvestigate2024-Q297.935.10Buyer-sourced3MARGINAL
AX-2024-004316QYB-2312-K5632VendorInvestigate2024-Q297.595.2889.5Buyer-sourced4MARGINAL
AX-2024-004317QYB-2312-K5632Janoshik2024-Q298.604.6994.6Supplier-supplied4MARGINAL
AX-2024-004318QYB-2312-K5632Nordanalyt2024-Q298.815.2391.6Supplier-supplied4MARGINAL
AX-2024-004319QYB-2312-K5632VendorInvestigate2024-Q297.415.14Buyer-sourced3MARGINAL
AX-2024-004320QYB-2312-K5632Janoshik2024-Q298.745.2995.6Supplier-supplied4MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
VendorInvestigate497.98, 97.93, 97.59, 97.4197.7632min-0.1197.87
Medutest198.8698.8625min+0.0898.78
Janoshik298.60, 98.7498.6730min+0.0098.67
Nordanalyt198.8198.8135min+0.0298.79

This lot contributes 6 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.9797.98divergence +0.68 pp vs batch median
Total impurities (% area)not stated2.02
Largest single impurity (% area)not stated1.38
Water (%)3.54.89
Counter-ion (%)not stated7.46
Peptide content (%w/w)not statednot determined
Endotoxin (EU/mg)2.50not determined
Method stated on certificateNOno method section — the result cannot be reconciled against any other
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
[D-Aib2]-diastereomer8 / 80.580.11–1.77
C18 diacid regioisomer8 / 80.170.05–0.41
oxidised Trp (+16 Da)8 / 80.060.03–0.11
des-Aib20 analogue8 / 80.200.03–0.69
aspartimide (−18 Da)4 / 80.150.10–0.19
retatrutide dimer4 / 80.040.03–0.05
incomplete Fmoc removal (+222 Da)4 / 80.610.52–1.30
truncated (5-39)2 / 80.030.02–0.04
Section 6

Shared-bulk links

Rule AX-R09. Where impurity fingerprints and latent composition match across companies, the index treats the material as one bulk and counts it once in aggregates.

LotSold byRoleReportsMedian purity
QSC-2404-P8297QSCparent bulk1498.62
QYB-2312-K5632QYBthis lot898.29
Section 7

What this rollup does not establish